CN1846756A - Amber bolus - Google Patents
Amber bolus Download PDFInfo
- Publication number
- CN1846756A CN1846756A CNA2005100462228A CN200510046222A CN1846756A CN 1846756 A CN1846756 A CN 1846756A CN A2005100462228 A CNA2005100462228 A CN A2005100462228A CN 200510046222 A CN200510046222 A CN 200510046222A CN 1846756 A CN1846756 A CN 1846756A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- bolus
- amber
- cornu cervi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims abstract description 43
- 238000002360 preparation method Methods 0.000 claims abstract description 15
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 12
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 12
- 241000628997 Flos Species 0.000 claims description 17
- 241000717739 Boswellia sacra Species 0.000 claims description 11
- 241001489978 Eupolyphaga Species 0.000 claims description 11
- 241001057584 Myrrha Species 0.000 claims description 11
- 239000009286 sanguis draxonis Substances 0.000 claims description 11
- 241000218176 Corydalis Species 0.000 claims description 10
- 241000237636 Pheretima Species 0.000 claims description 10
- 238000005242 forging Methods 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- 241000545442 Radix Species 0.000 claims description 9
- 239000006187 pill Substances 0.000 claims description 5
- 238000007689 inspection Methods 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 208000010392 Bone Fractures Diseases 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 14
- 208000026137 Soft tissue injury Diseases 0.000 abstract description 8
- 235000012907 honey Nutrition 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- 241001116742 Drynaria Species 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 206010017076 Fracture Diseases 0.000 description 19
- 208000002193 Pain Diseases 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 18
- 239000008280 blood Substances 0.000 description 18
- 210000000988 bone and bone Anatomy 0.000 description 17
- 230000001737 promoting effect Effects 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 210000002435 tendon Anatomy 0.000 description 10
- 238000002347 injection Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 6
- 208000007536 Thrombosis Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 230000035876 healing Effects 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 239000004863 Frankincense Substances 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 238000009940 knitting Methods 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 241001419719 Anisodus carniolicoides Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000002565 Open Fractures Diseases 0.000 description 1
- 206010031264 Osteonecrosis Diseases 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 206010034122 Patella fracture Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to fracture setting medicine, and is especially Chinese medicine for treating fracture and soft tissue injury and its preparation process. The Chinese medicine for treating fracture and soft tissue injury is prepared with amber, native copper, notoginseng, drynaria rhizome, teaset root and other 14 kinds of Chinese medicinal materials, and through material sorting, drying, crushing to 120 mesh and mixing with honey to form bolus. The Chinese medicine has determined curative effect and simple preparation process.
Description
Technical field
The present invention relates to a kind of bone-setting medicament for the treatment of fracture, is the Chinese patent medicine of preparation of raw material with the Chinese herbal medicine specifically, can treat fracture and soft tissue injury, the invention still further relates to the preparation method of this medicine.
Background technology
For the treatment of fracture and soft tissue injury, doctor trained in Western medicine mainly is to adopt the antibiotic anti-inflammatory analgetic, and takes vitamins and calcium preparation; The traditional Chinese medical science mainly is to adopt promoting blood circulation and stopping pain, eliminating blood stasis to promote regeneration of blood, reunion of fractured tendons and bones class Chinese medicine preparation.Chinese medicine once used Chinese medicine preparation such as pill for traumatic injuries, powder for traumatic injuries, JIUFEN POWDER, Anisodus carniolicoides C.Y.Wu et C.Chen clinically, because said medicine exists gastrointestinal tract is had the stimulation side effect, and medicine stability was poor, and curative effect is not good enough, and country has notified and stopped using.Mainly use Flos Carthami injection, SHENYANG HONGYAO, Cortex torricelliae tiliifoliae etc. at present clinically, the main pharmacological of Flos Carthami injection and SHENYANG HONGYAO is promoting blood circulation and stopping pain, eliminating blood stasis to promote regeneration of blood, and the effect of reunion of fractured tendons and bones is little; Though Cortex torricelliae tiliifoliae is having certain effect aspect reducing swelling and alleviating pain, the reunion of fractured tendons and bones, exist shortcomings such as treatment cycle is long, uncertain therapeutic efficacy is cut.Western medicine mainly use to promote clinically the calcium preparation of knitting such as bone peptide injection, soft spirit etc., but exist shortcomings such as treatment cycle is long, uncertain therapeutic efficacy is cut, and cost an arm and a leg, general patient is difficult to bear.The deficiency that above medicine exists is the problem that relevant medical department is comparatively paid close attention to always.
Summary of the invention
The objective of the invention is deficiency, provide a kind of for treatment fracture and soft tissue injury determined curative effect, the more satisfactory medicine amber bolus that treatment cycle is short at the said medicine existence.
Another object of the present invention provides the preparation method of this amber bolus.
The present invention makes (consumption is a weight portion) by the raw material of following Chinese herbal medicine:
5～25 parts of Pyritums (forging), 5～25 parts of Radix Notoginseng, 4～15 parts of Rhizoma Drynariae (system), 4～15 parts of Radix Dipsacis, 4～15 parts of Herba Taxillis, 8～25 parts of Eupolyphaga Seu Steleophagas, 5～25 parts of Sanguis Draxonis, 80～150 parts on Flos Carthami, 10～25 parts of Olibanums (system), 10～25 parts of Myrrha (processed), 4～15 parts of Radix Angelicae Sinensis, 8～25 parts of Pheretimas, 4～15 parts in Cornu Cervi Pantotrichum, 100～240 parts of Cornu Cervi Degelatinatums, 10～50 parts of succinums, 8～25 parts of the Radixs Angelicae Dahuricae, 8～25 parts of Cortex Mori, 6～15 parts of Radix Paeoniae Rubra, 6～15 parts of Rhizoma Corydalis.
The present invention is to be monarch drug with the Pyritum (calcined), eliminating stasis to stop pain, reunion of bone.Pyritum (forging) promoting the circulation of bloodization stagnates, and the merit of eliminating stasis to stop pain is arranged, and can synthetism hinder to treat folding, is the traumatology medication.Radix Notoginseng, Eupolyphaga Seu Steleophaga, Rhizoma Drynariae (system), Radix Dipsaci, Herba Taxilli, Sanguis Draxonis, Flos Carthami, Olibanum (system), Myrrha (processed) activating blood circulation and dissipating blood stasis, reunion of fractured tendons and bones, the energy liver and kidney tonifying of holding concurrently to help Pyritum (forging) efficacy of a drug, is ministerial drug.Radix Notoginseng hemostasis and do not stay the stasis of blood is used for traumatic injury, the stasis of blood stagnates and swells and ache, and the merit of blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain is arranged, and is longer than pain relieving especially.But the Sanguis Draxonis external, also oral administration takes the promoting blood circulation to remove blood stasis pain relieving orally.The Flos Carthami blood circulation promoting and blood stasis dispelling, stimulate the menstrual flow.The merit of this product blood circulation promoting and blood stasis dispelling is excellent, to traumatic injury, stasis of blood pain, arthralgia, with compatibilities such as Olibanum (system), Myrrha (processed), strengthens the promoting blood circulation to remove blood stasis effect, altogether the power of principal drug assistance.It is capable stagnant to increase the Radix Paeoniae Rubra blood stasis dispelling, alleviating pain.Eupolyphaga Seu Steleophaga, Rhizoma Drynariae (system), Radix Dipsaci, Herba Taxilli, but invigorating the liver and kidney reuniting the fractured tendons and bones.The traditional Chinese medical science is thought " The liver and the kidney have a common source " liver and kidney tonifying, can beneficial menses, the Shujin bone.The above-mentioned invigorating the liver and kidney of Fang Zhongyong, reunion of fractured tendons and bones can be total to the merit of principal drug assistance.Radix Angelicae Sinensis, Pheretima promoting blood circulation to restore menstrual flow add the Rhizoma Corydalis promoting the circulation of QI to relieve pain, to help pseudo-ginseng blood-circulation-invigovating, to nourish blood.Cornu Cervi Pantotrichum, Cornu Cervi Degelatinatum aid yang qi are restrained granulation promoting, and can be stopped blooding with hemopoietic.The succinum tranquillizing the mind by relieving convulsion is an adjuvant drug.The Cornu Cervi Degelatinatum kidney tonifying is supporing yang, contains abundant calcareously, and the merit of the existing liver and kidney tonifying of a large amount of Cornu Cervi Degelatinatums of Fang Zhongyong can be replenished the calcium again.Bone decreases the injury of tendon and muscle, swelling and pain due to blood stasis.Patient's initial stage pain is lain awake all night unbearably, and succinum can play the effect of tranquillizing the mind by relieving convulsion.The Radix Angelicae Dahuricae, Cortex Mori dampness, dampness removing, it is a messenger drug, all medicines share, but reunion of fractured tendons and bones, blood circulation promoting and blood stasis dispelling.The dehumidifying of nourishing blood all promotes callus formation, helps the power of reunion of fractured tendons and bones.
The proportion optimization weight (part) of medicine of the present invention is: 10～20 parts of Pyritums (forging), 10～20 parts of Radix Notoginseng, 6～10 parts of Rhizoma Drynariae (system), 6～10 parts of Radix Dipsacis, 6～10 parts of Herba Taxillis, 10～23 parts of Eupolyphaga Seu Steleophagas, 10～20 parts of Sanguis Draxonis, 100～130 parts on Flos Carthami, 15～22 parts of Olibanums (system), 15～22 parts of Myrrha (processed), 6～10 parts of Radix Angelicae Sinensis, 12～23 parts of Pheretimas, 6～10 parts in Cornu Cervi Pantotrichum, 150～200 parts of Cornu Cervi Degelatinatums, 20～40 parts of succinums, 12～23 parts of the Radixs Angelicae Dahuricae, 12～23 parts of Cortex Mori, 6～12 parts of Radix Paeoniae Rubra, 6～12 parts of Rhizoma Corydalis.
Preferable weight (part) proportioning of medicine of the present invention is: 20 parts of Pyritums (forging), 20 parts of Radix Notoginseng, 10 parts of Rhizoma Drynariae (system), 10 parts of Radix Dipsacis, 10 parts of Herba Taxillis, 23 parts of Eupolyphaga Seu Steleophagas, 20 parts of Sanguis Draxonis, 130 parts on Flos Carthami, 22 parts of Olibanums (system), 22 parts of Myrrha (processed), 10 parts of Radix Angelicae Sinensis, 23 parts of Pheretimas, 10 parts in Cornu Cervi Pantotrichum, 200 parts of Cornu Cervi Degelatinatums, 40 parts of succinums, 23 parts of the Radixs Angelicae Dahuricae, 23 parts of Cortex Mori, 12 parts of Radix Paeoniae Rubra, 12 parts of Rhizoma Corydalis.
Making preparation method of the present invention is: with raw material screen respectively, dry, pulverized 120 mesh sieves, autoclaving, treat pulverous medicine after medicine inspection is qualified with water content 5～10%, density be the Mel of 1.38～1.40g/ml by 1: 1 mixed, stir, make pill.
The given medicine of the present invention is when treatment fracture and soft tissue injury, not only can play rapid detumescence, pain relieving, reunion of fractured tendons and bones effect, and can shorten the healing time of fracture patient, to treatment open fracture, bone do not connect, delayed union disease and osteonecrosis, soft tissue injury etc. have good effect, its determined curative effect, treatment cycle is short, does not have secondary the use, is the ideal medicament of a kind of quickly treating fracture and soft tissue injury.The preparation method of this medicine is simple, is easy to processing, is convenient to clinical use.
The specific embodiment
Embodiment 1
Take by weighing raw material by following weight proportion:
With 25 parts of Pyritums (forging), 25 parts of Radix Notoginseng, 15 parts of Rhizoma Drynariae (system), 15 parts of Radix Dipsacis, 15 parts of Herba Taxillis, 25 parts of Eupolyphaga Seu Steleophagas, 25 parts of Sanguis Draxonis, 150 parts on Flos Carthami, 25 parts of Olibanums (system), 25 parts of Myrrha (processed), 15 parts of Radix Angelicae Sinensis, 25 parts of Pheretimas, 15 parts in Cornu Cervi Pantotrichum, 240 parts of Cornu Cervi Degelatinatums, 50 parts of succinums, 25 parts of the Radixs Angelicae Dahuricae, 25 parts of Cortex Mori, 15 parts of Radix Paeoniae Rubra, 15 parts of Rhizoma Corydalis.
Preparation method is as follows: raw material screens respectively, dry, pulverized 120 mesh sieves, autoclaving, powdery medicine are pressed 1: 1 mixed with refining Mel (water content 5～10%, density are the old honey of 1.38～1.40/ml) well after medicine inspection is qualified, stir promptly available pellet processing machine processing pill.
Embodiment 2
Get 5 parts of Pyritums (forging), 5 parts of Radix Notoginseng, 4 parts of Rhizoma Drynariae (system), 4 parts of Radix Dipsacis, 4 parts of Herba Taxillis, 8 parts of Eupolyphaga Seu Steleophagas, 5 parts of Sanguis Draxonis, 80 parts on Flos Carthami, 10 parts of Olibanums (system), 10 parts of Myrrha (processed), 4 parts of Radix Angelicae Sinensis, 8 parts of Pheretimas, 4 parts in Cornu Cervi Pantotrichum, 100 parts of Cornu Cervi Degelatinatums, 10 parts of succinums, 8 parts of the Radixs Angelicae Dahuricae, 8 parts of Cortex Mori, 6 parts of Radix Paeoniae Rubra, 6 parts of Rhizoma Corydalis.Preparation method is with embodiment 1.
Embodiment 3
Get 10 parts of Chinese herbal medicine Pyritum (calcined)s, 10 parts of Radix Notoginseng, 8 parts of Rhizoma Drynariae (processed)s, 9 parts of Radix Dipsacis, 8 parts of Herba Taxillis, 10 parts of Eupolyphaga Seu Steleophagas, 12 parts of Sanguis Draxonis, 100 parts on Flos Carthami, 15 parts of Olibanum (processed)s, 15 parts of Myrrha (processed)s, 7 parts of Radix Angelicae Sinensis, 12 parts of Pheretimas, 6 parts in Cornu Cervi Pantotrichum, 150 parts of Cornu Cervi Degelatinatums, 20 parts of succinums, 13 parts of the Radixs Angelicae Dahuricae, 13 parts of Cortex Mori, 10 parts of Radix Paeoniae Rubra, 10 parts of Rhizoma Corydalis.Preparation method is with embodiment 1.
The present invention can make powder, tablet, capsule or soft capsule.
Case:
1. Yin, the man, 18 years old, right fracture of medial malleolus, the serious edema of fracture site, skin is dark violet, pain unbearably, patient's emotion lather.The row manual reduction, plaster splint external fixation treatment, oral amber bolus is simultaneously taken amber bolus that the present invention provides after one week, and symptom is obviously improved, and patient is irritated, and emotion fades away, and pain obviously alleviates, and the fracture site skin color progressively recovers normally, the edema disappearance.After taking medicine one month, the inspection of X-ray sheet shows that fracture line is fuzzy, and patient's local pain of fracturing disappears substantially, continues oral amber bolus after two weeks, and X-ray film shows that fracture line disappears, and having a medical check-up meets the clinical union of bone sign.
2. Lee, man, 58 years old, the right hand the 4.5th metacarpal fracture, palm redness during patient admission, heating, with dull pain, feeling of numbness.The row manual reduction, the clamping plate external fixation cooperates and takes the amber bolus that the present invention provides, and after the week of taking medicine, symptom is obviously improved.Red and swollen, heating alleviates, and dull pain, feeling of numbness disappear, and patient is emotionally stable, and through X-ray examination, the fracture good apposition has a small amount of callus.Continue oral amber bolus after three weeks, clinical symptoms and sign are recovered normally substantially, and X-ray film shows that fracture line disappears, and a large amount of growth of spur are arranged, and fracture reaches clinical healing.
3. Ma, man, 60 years old, left Patella fracture operative treatment.Normal anti-inflammatory treatment began to take the amber bolus (pressing the given pill of embodiment 1 proportioning raw materials) that the present invention provides after one week, around the postoperative, clapped the check of X-ray sheet, and fracture line is fuzzy, and patient's knee joint begins functional exercise, and in seven weeks of postoperative, fracture reaches clinical healing.
Comparative example: the amber bolus that the present invention provides and the contrast of Western medicine
1. contrast with the drug for invigorating blood circulation and eliminating stasis Flos Carthami injection
The influence that medicine forms external thrombus
| Group | The clinical experiment number | Thrombus formation time (second) | Thrombosis length (cm) | Wet weight of thrombus (mg) | Thrombosis dry weight (mg) |
| Model group | 30 | 179.2±46.1 | 5.7±0.6 | 152.6±18.7 | 41.9±5.6 |
| Flos Carthami injection | 30 | 418.8±75.5 | 3.9±0.7 | 79.0±18.1 | 21.9±5.9 |
| Amber bolus | 30 | 573.6±37.2 | 2.5±0.4 | 51.6±17.4 | 15.4±4.3 |
As can be seen from the table, Flos Carthami injection and amber bolus all have the thrombotic effect of inhibition, but amber bolus anti-thrombosis function more remarkable effect.
2. with the contrast that promotes the knitting bone peptide injection
Medicine is done the influence of union of fracture to human femur under loading
| Group | The clinical experiment number | The callus formation time (my god) | Osteoclast occur the position (my god) | Healing time (my god) |
| Model group | 20 | 15±2 | Few | 45±10 |
| Flos Carthami injection | 20 | 12±3 | Many | 38±9 |
| Amber bolus | 20 | 10±2 | At most | 30±6 |
As can be seen from the table, bone peptide injection and amber bolus all have the effect that promotes knitting, but the action effect of amber bolus is more obvious.
Claims (5)
1. amber bolus is characterized in that it is to be made by the following weight proportion raw material:
5～25 parts of Pyritums (forging), 5～25 parts of Radix Notoginseng, 4～15 parts of Rhizoma Drynariae (system), 4～15 parts of Radix Dipsacis, 4～15 parts of Herba Taxillis, 8～25 parts of Eupolyphaga Seu Steleophagas, 5～25 parts of Sanguis Draxonis, 80～150 parts on Flos Carthami, 10～25 parts of Olibanums (system), 10～25 parts of Myrrha (processed), 4～15 parts of Radix Angelicae Sinensis, 8～25 parts of Pheretimas, 4～15 parts in Cornu Cervi Pantotrichum, 100～240 parts of Cornu Cervi Degelatinatums, 10～50 parts of succinums, 8～25 parts of the Radixs Angelicae Dahuricae, 8～25 parts of Cortex Mori, 6～15 parts of Radix Paeoniae Rubra, 6～15 parts of Rhizoma Corydalis.
2. according to the described amber bolus of claim 1, it is characterized in that the weight proportion of each raw material is:
10～20 parts of Pyritums (forging), 10～20 parts of Radix Notoginseng, 6～10 parts of Rhizoma Drynariae (system), 6～10 parts of Radix Dipsacis, 6～10 parts of Herba Taxillis, 10～23 parts of Eupolyphaga Seu Steleophagas, 10～20 parts of Sanguis Draxonis, 100～130 parts on Flos Carthami, 15～22 parts of Olibanums (system), 15～22 parts of Myrrha (processed), 6～10 parts of Radix Angelicae Sinensis, 12～23 parts of Pheretimas, 6～10 parts in Cornu Cervi Pantotrichum, 150～200 parts of Cornu Cervi Degelatinatums, 20～40 parts of succinums, 12～23 parts of the Radixs Angelicae Dahuricae, 12～23 parts of Cortex Mori, 6～12 parts of Radix Paeoniae Rubra, 6～12 parts of Rhizoma Corydalis.
3. according to the described amber bolus of claim 1, it is characterized in that the weight proportion of each raw material is:
20 parts of Pyritums (forging), 20 parts of Radix Notoginseng, 10 parts of Rhizoma Drynariae (system), 10 parts of Radix Dipsacis, 10 parts of Herba Taxillis, 23 parts of Eupolyphaga Seu Steleophagas, 20 parts of Sanguis Draxonis, 130 parts on Flos Carthami, 22 parts of Olibanums (system), 22 parts of Myrrha (processed), 10 parts of Radix Angelicae Sinensis, 23 parts of Pheretimas, 10 parts in Cornu Cervi Pantotrichum, 200 parts of Cornu Cervi Degelatinatums, 40 parts of succinums, 23 parts of the Radixs Angelicae Dahuricae, 23 parts of Cortex Mori, 12 parts of Radix Paeoniae Rubra, 12 parts of Rhizoma Corydalis.
4. preparation method of amber bolus according to claim 1, it is characterized in that with raw material screen respectively, dry, pulverized 120 mesh sieves, autoclaving, treat that pulverous medicine is that the Mel of 1.38～1.40g/ml was by 1: 1 mixed with water content 5～10%, density after medicine inspection is qualified, stir, make pill.
5. according to the described amber bolus of claim 1, it is characterized in that to make powder, tablet, capsule or soft capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100462228A CN100411661C (en) | 2005-04-12 | 2005-04-12 | Amber bolus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100462228A CN100411661C (en) | 2005-04-12 | 2005-04-12 | Amber bolus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1846756A true CN1846756A (en) | 2006-10-18 |
| CN100411661C CN100411661C (en) | 2008-08-20 |
Family
ID=37076637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100462228A Expired - Fee Related CN100411661C (en) | 2005-04-12 | 2005-04-12 | Amber bolus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100411661C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552612A (en) * | 2012-03-05 | 2012-07-11 | 肖玉臣 | Traditional Chinese medicine for setting fracture |
| CN102895333A (en) * | 2012-10-30 | 2013-01-30 | 冯悦 | Chinese medicinal preparation for treating soft tissue injury |
| CN104258215A (en) * | 2013-06-18 | 2015-01-07 | 张方元 | Preparation method of agent for treating fractures |
| CN114949104A (en) * | 2022-05-24 | 2022-08-30 | 大连大学附属中山医院 | A Chinese medicinal oral preparation for promoting early healing of fracture and traumatic injury repair, and its preparation method |
-
2005
- 2005-04-12 CN CNB2005100462228A patent/CN100411661C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552612A (en) * | 2012-03-05 | 2012-07-11 | 肖玉臣 | Traditional Chinese medicine for setting fracture |
| CN102552612B (en) * | 2012-03-05 | 2014-04-02 | 肖玉臣 | Traditional Chinese medicine for setting fracture |
| CN102895333A (en) * | 2012-10-30 | 2013-01-30 | 冯悦 | Chinese medicinal preparation for treating soft tissue injury |
| CN104258215A (en) * | 2013-06-18 | 2015-01-07 | 张方元 | Preparation method of agent for treating fractures |
| CN114949104A (en) * | 2022-05-24 | 2022-08-30 | 大连大学附属中山医院 | A Chinese medicinal oral preparation for promoting early healing of fracture and traumatic injury repair, and its preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100411661C (en) | 2008-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102091202B (en) | Traditional Chinese medicinal composition for treating fracture and preparation method thereof | |
| CN101181453B (en) | Chinese medicine preparation for curing orthopaedics sickness | |
| CN101703757B (en) | Plaster for reuniting fractured tendons and bones and activating blood, and preparation method thereof | |
| CN100394955C (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
| CN101352505B (en) | Bone fracture setting medicine powder for treating traumatic injury | |
| CN1853664A (en) | Medicinal composition for treating wound and preparation thereof | |
| CN102379941B (en) | A kind of compound Chinese medicinal preparation treating fracture and preparation method thereof | |
| CN101961431A (en) | Ointment for treating bone fractures | |
| CN1876130A (en) | A medicinal plaster and method for making same | |
| CN101234153A (en) | Externally-applied medicament for treating bone fracture | |
| CN100484538C (en) | Upper, middle and lower part soup, and method for making same | |
| CN101007040B (en) | External applied medicine for treating bone fractures | |
| CN100345573C (en) | Medicine for treating traumatic injury | |
| CN100411661C (en) | Amber bolus | |
| CN101637549A (en) | Medicine for treating fracture | |
| CN101862419A (en) | Externally applied medicament for treating closed bone injuries | |
| CN100522216C (en) | Medicine for treating traumatic injury | |
| CN100562336C (en) | HUOXUEDAN and preparation method thereof | |
| CN103027978A (en) | Medicine composition for treating traumatic injury and preparation method of medicine composition | |
| CN1824103A (en) | External use medicine for treating knocks and falls and bone joining | |
| CN1454660A (en) | Bone-setting medicine | |
| CN102499963B (en) | Traditional Chinese medicine compound for treating fracture | |
| CN1559581A (en) | External use medicine for bone-knitting | |
| CN103417944A (en) | Swelling diminishing, blood activating and fracture healing ointment and method for manufacturing same | |
| CN101088534B (en) | Medicine composition for treating bone necrosis and its preparation process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080820 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |